Ceftazidime-Avibactam Versus Polymyxin-Based Combination Therapies: A Study on 30-Day Mortality in Carbapenem-Resistant Enterobacterales Bloodstream Infections in an OXA-48-Endemic Region

• Автори: Rıdvan Dumlu (Автор), Meyha Şahin (Автор), Okan Derin (Автор), Özlem Gül (Автор), Sedef Başgönül (Автор), Rehile Zengin (Автор), Çiğdem Arabacı (Автор), Funda Şimşek (Автор), Serap Gençer (Автор), Ayşe Sesin Kocagöz (Автор), Ali Mert (Автор)
• Формат: Книга
• Опубліковано: MDPI AG, 2024-10-01T00:00:00Z.
• Предмети: article
• Онлайн доступ: Connect to this object online.

<b>Background</b>: Ceftazidime-avibactam (CAZ-AVI) is recommended as first-line treatment for Oxacillinase-48 (OXA-48) β-Lactamase-producing carbapenem-resistant Enterobacterales (CRE) infections, while polymyxin-based combination therapies (PBCTs) are used as a last resort when CAZ-AVI...